key: cord-0832561-dmgn26wt
authors: Bhatt, Ankeet S.; Vaduganathan, Muthiah
title: Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?
date: 2020-11-24
journal: J Am Coll Cardiol
DOI: 10.1016/j.jacc.2020.09.548
sha: 9d9153572ed63c6d1948886bde3ee1404dfa1902
doc_id: 832561
cord_uid: dmgn26wt

nan

We read with interest the paper by Moonsamy et al. (1) and its associated editorial (2). The authors reported a plant. An approach of longer-term temporary mechanical circulatory support (MCS) (e.g., Impella 5.0, Centrimag) to allow for end-organ recovery, followed by reassessment of suitability for advanced HF therapies, may provide more judicious use of invasive and expensive durable MCS or scarce organs.

There is significant heterogeneity within ECMOsupported patients with prognostic implications.

Thus, placing all ECMO-supported patients in a single group may not be appropriate. Further investigation is needed to risk-stratify these patients and to identify the best strategy to help patients who are critically ill and in need of advanced HF therapies. 

Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 Pandemic